- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03969238
Utilizing Helpline for Opioid Dependence Treatment
Study Overview
Detailed Description
The proposed specific aims are to:
- Test if the helpline is a resourceful tool for patients with opioid use disorder looking for referrals and support to access treatment. The opioid helpline will provide individuals with opioid use disorder seeking treatment, direct access to a live person who can answer questions regarding referrals and various treatment programs. The helpline will also follow-up on treatment compliance and offer support and motivational techniques for these individuals to stay engaged in treatment
- Test if the helpline is a resourceful tool for patients with new onset of pain or chronic pain being prescribed opioids. The opioid helpline will provide these individuals the necessary educational materials on managing pain safely while avoiding misuse. It will offer free imagery guided meditation and other non-pharmacological tools to help with pain management.
- Test if providers find the opioid helpline helpful and resourceful for their practice and are willing to refer patients to the helpline.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Eva Jenkins-Mendoza
- Phone Number: (434)243-0562
- Email: emj9c@virginia.edu
Study Contact Backup
- Name: Tracie Kostelac
- Phone Number: (434)243-0563
- Email: tlk5d@virginia.edu
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22903
- Recruiting
- UVA Center for Leading Edge Addiction Research
-
Contact:
- Eva Jenkins-Mendoza
- Phone Number: (434)243-0562
- Email: emj9c@virginia.edu
-
Contact:
- Tracie Kostelac
- Phone Number: 434-243-0563
- Email: tlk5d@virginia.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
We plan to pilot this model in a small rural area with low accessibility to specialized treatment. We will specifically target the area of county of Wise as it is an area with one of the highest rate of opioid addiction and overdose related deaths in the state.
UVA hospital: we plan to pilot this model at UVA hospital because it is a health care system offering care to a diverse population from urban and rural areas.
The providers will be educated regarding the goals and objectives of the helpline: Any specialty physicians, nurses including dentists that prescribes opioids within Virginia They will be asked to have flyers about the helpline in their office and refer patients who are prescribed opioids to get more support from the helpline.
Description
Inclusion Criteria:
Participant Criteria:
- Age greater than or equal to 18 years.
- A formal diagnosis of Opioid Use Disorder (OUD) by a health care provider or
- If no formal diagnosis of OUD, having a self-reported concern with opioid use or addiction.
- An individual seeking to reduce opioid use.
- An individual concerned about opioids prescribed for management of new-onset pain or chronic pain.
Provider Criteria:
- University of Virginia: Providers of any specialties within VA including dentists that prescribes opioids.
- County of Wise: Providers of any specialties including dentists that prescribes opioids.
Exclusion Criteria:
Participant Criteria:
- Individuals under 18 years of age.
- Individuals seeking treatment for non-opioid substance use disorders
- Individuals who have no pain issues
- Individuals located outside of Virginia.
Provider Criteria:
Providers outside the designated regions.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients/Providers
Of the1,000 participants: (1) 900 will enroll as participants who use the helpline resources via verbal consent and (2) 100 will enroll as providers via online consent prior to survey data collection.
|
This helpline will aim to provide patients with new diagnosis of pain who are prescribed opioids, access to education, support and free behavioral technique to help manage their pain such as mindfulness exercises.
For those with opioid use disorder, the helpline will offer support in the form of education about the disorder, opioid withdrawal symptoms, risks of overdoses, and a variety of services such as help reach appropriate care with MAT licensed providers, information on FDA-approved MAT and naloxone, and, in some cases, behavioral intervention to keep patients engaged in treatment.
The opioid helpline will provide a central resource for direct services and a portal for community services.
It will also serve as a referral resource for health-care professionals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participant Opioid Helpline Survey
Time Frame: up to a year
|
Primary outcomes measure the rating of the Helpline by the patients.
They will be sent surveys that will ask the patients to rate the services they receive on a scale of 1 to 10, with 1 meaning they are very dissatisfied and 10 meaning they are very satisfied.
|
up to a year
|
Provider Opioid Helpline Survey
Time Frame: up to a year
|
Primary outcomes measure the rating of the Helpline by the providers.
They will be sent surveys that will ask the providers to rate the services they receive on a scale of 1 to 10, with 1 meaning they are very dissatisfied and 10 meaning they are very satisfied.
|
up to a year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants reached versus called.
Time Frame: up to a year
|
Total number of contacts to the Helpline compared to the number that prescreened and the number consented.
|
up to a year
|
Number of participants who continued to access the services of Helpline
Time Frame: up to a year
|
The investigator will measure the number of participants who continued to access the services of Helpline up to a year.
|
up to a year
|
New General Self-Efficacy Measure
Time Frame: up to a year
|
By using this survey, the investigator will determine the participant's ability to handle the situation that prompted the participant to call the Helpline originally.
|
up to a year
|
Opioid Helpline Study Screen Form
Time Frame: up to a year
|
This will be use to collect demographic information for individuals who self-identify as needing help or resources from the Helpline.
|
up to a year
|
Referral follow-ups
Time Frame: up to a year
|
Assess which referrals were followed up on by the participants.
|
up to a year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21376
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Opioid Dependence
-
National Development and Research Institutes, Inc.Unknown
-
MindLight, LLCMclean HospitalRecruitingOpioid Dependence | Opioid Use | Opioid Abuse | Opiate Dependence | Opioid Use, Unspecified | Opioid Use Disorder, ModerateUnited States
-
Milton S. Hershey Medical CenterRecruitingOpioid Dependence FentanylUnited States
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)Completed
-
Orexo ABWorldwide Clinical TrialsCompletedOpioid Dependence, on Agonist TherapyUnited States
-
National Development and Research Institutes, Inc.St. Luke's-Roosevelt Hospital CenterUnknownOpioid-Dependence Among AdolescentsUnited States
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA)CompletedOpioid Dependence | Opioid-use Disorder | Opiate DependenceUnited States
-
Orexo ABWorldwide Clinical TrialsCompletedOpioid Dependence, on Agonist TherapyUnited States
-
Indivior Inc.CompletedOpioid Dependence | Cocaine Dependence | Opioid Related DisordersUnited States
-
NYU Langone HealthNational Institute on Drug Abuse (NIDA)Completed
Clinical Trials on Helpline
-
University of OklahomaRecruitingSmoking CessationUnited States
-
Vanderbilt UniversityTerminatedObesity | Type 2 Diabetes Mellitus | Exercise | Behavioral ResearchUnited States
-
MaineHealthCompletedPneumonia | Asthma | Tobacco Cessation | Tobacco Smoking | Bronchiolitis | Bronchopulmonary Dysplasia | Reactive Airway DiseaseUnited States
-
Vanderbilt University Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2United States
-
Oregon Research InstituteNational Cancer Institute (NCI); University of California, San DiegoCompletedTobacco Use DisorderUnited States
-
Vanderbilt University Medical CenterCompletedDiabetes Mellitus, Type 2United States
-
Brown UniversityRecruitingAlcohol; Harmful Use | Sexually Transmitted Diseases, BacterialUnited States